RASUVO

Generic: METHOTREXATE

Manufacturer: Medexus Pharma Inc.

Folate Analog Metabolic Inhibitor [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]Vitamin C [EPC]Vitamin B12 [EPC]
406,912
Total Reports
130,101
Serious Reports
32,442
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.97%)

Patient Demographics

Male
106,605
Female
257,292

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for RASUVO.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 74,709
11.8%
2 RHEUMATOID ARTHRITIS 37,861
6.0%
3 ARTHRALGIA 36,108
5.7%
4 PAIN 35,256
5.6%
5 OFF LABEL USE 33,392
5.3%
6 FATIGUE 28,906
4.6%
7 NAUSEA 23,855
3.8%
8 JOINT SWELLING 22,229
3.5%
9 HEADACHE 20,715
3.3%
10 RASH 19,737
3.1%
11 CONDITION AGGRAVATED 19,561
3.1%
12 DRUG INTOLERANCE 19,520
3.1%
13 DIARRHOEA 18,140
2.9%
14 PAIN IN EXTREMITY 17,781
2.8%
15 PYREXIA 16,870
2.7%
16 PNEUMONIA 16,059
2.5%
17 MALAISE 15,065
2.4%
18 VOMITING 14,952
2.4%
19 ALOPECIA 14,631
2.3%
20 TREATMENT FAILURE 14,430
2.3%
21 DYSPNOEA 14,328
2.3%
22 NASOPHARYNGITIS 14,047
2.2%
23 ABDOMINAL DISCOMFORT 14,024
2.2%
24 INJECTION SITE PAIN 13,847
2.2%
25 INFECTION 13,433
2.1%
26 PERIPHERAL SWELLING 13,188
2.1%
27 ARTHROPATHY 13,154
2.1%
28 CONTRAINDICATED PRODUCT ADMINISTERED 12,937
2.0%
29 MUSCULOSKELETAL STIFFNESS 12,904
2.0%
30 DRUG HYPERSENSITIVITY 12,366
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.